Anesthetic concerns during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Anesthetic concerns during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Bibliographic Details
Main Authors:	Jung-Hee Ryu, Chang-Hoon Koo
Format:	Article
Language:	English
Published:	Korean Society of Anesthesiologists 2021-04-01
Series:	Korean Journal of Anesthesiology
Online Access:	http://ekja.org/upload/pdf/kja-21099.pdf

Similar Items

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
by: Adriana C. Gamboa, et al.
Published: (2019-10-01)

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
by: Natasha Leigh, et al.
Published: (2020-06-01)

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
by: Kavita Murughan, et al.
Published: (2014-01-01)

Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge
by: Bartos Adrian, et al.
Published: (2017-10-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Fluid and temperature remain the culprit!
by: Rakesh Garg
Published: (2018-01-01)

Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
by: Renato Gomes Campanati, et al.
Published: (2014-01-01)

Patient-Reported Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Rinius, Benjamin
Published: (2018)

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy on Huge Retroperitoneal Liposarcoma
by: YANG Peigang, et al.
Published: (2021-01-01)

Anesthetic implications in hyperthermic intraperitoneal chemotherapy
by: Nishkarsh Gupta, et al.
Published: (2019-01-01)

Incidence and predictors of incisional hernia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Todd M. Tuttle, et al.
Published: (2019-01-01)

Short-term Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Özgül Düzgün, et al.
Published: (2018-06-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Loss Martin, et al.
Published: (2004-06-01)

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
by: Rob Bielen, et al.
Published: (2013-01-01)

Four different methods of measuring cardiac index during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Amon Heijne, et al.
Published: (2021-04-01)

Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Chao-Yu Chen, et al.
Published: (2020-01-01)

The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Jolene Si Min Wong, et al.
Published: (2020-01-01)

Patterns and predictors of outpatient opioid use after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
by: Pascal Owusu-Agyemang, et al.
Published: (2019-01-01)

Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
by: Bradley H King, et al.
Published: (2020-01-01)

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients
by: Anna Weiss, et al.
Published: (2018-04-01)

Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
by: Hamed Elgendy, et al.
Published: (2019-01-01)

Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?
by: Horacio N. López-Basave, et al.
Published: (2014-01-01)

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations
by: Enomoto LM, et al.
Published: (2019-05-01)

The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Natasha Leigh, et al.
Published: (2020-07-01)

Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study
by: Paul Dranichnikov, et al.
Published: (2020-04-01)

Morbidity and Mortality Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy at a Single Institution in Japan
by: Akiyoshi Mizumoto, et al.
Published: (2012-01-01)

Peritoneal Dissemination of Hepatoid Carcinoma of the Ovary Treated with Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy
by: Pedro Antonio Cascales Campos, et al.
Published: (2013-01-01)

Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Intraoperative Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer
by: Antonios-Apostolos K. Tentes, et al.
Published: (2012-01-01)

Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A retrospective analysis
by: Kalpana P Balakrishnan, et al.
Published: (2018-01-01)

Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
by: Skierucha Malgorzata, et al.
Published: (2017-12-01)

Utility of lung ultrasound for extravascular lung water volume estimation during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Amit Kumar Mittal, et al.
Published: (2021-01-01)

Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers
by: McKayla J. Riggs, et al.
Published: (2020-08-01)

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study
by: M. Leimkühler, et al.
Published: (2019-01-01)

Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index
by: Bertrand Trilling, et al.
Published: (2021-02-01)

Prevention of Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Development of a Physiotherapy Program
by: Xin-Bao Li MD, et al.
Published: (2019-11-01)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
by: Yu HH, et al.
Published: (2019-01-01)

The impact of urological resection and reconstruction on patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Grace Hwei Ching Tan, et al.
Published: (2018-07-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. V. Shelekhov, et al.
Published: (2018-07-01)

Changes in Hepatic Blood Flow and Liver Function during Closed Abdominal Hyperthermic Intraperitoneal Chemotherapy following Cytoreduction Surgery
by: Stéphanie Dupont, et al.
Published: (2018-01-01)

Work Environment in the Operating Room during Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy : Factors Influencing Choice of Protective Equipment
by: Näslund Andréasson, Sara
Published: (2011)

Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma
by: A. G. Abdullayev, et al.
Published: (2014-08-01)